Lupin Limited (LUPIN) - Total Assets

Latest as of September 2025: Rs335.00 Billion INR ≈ $3.62 Billion USD

Based on the latest financial reports, Lupin Limited (LUPIN) holds total assets worth Rs335.00 Billion INR (≈ $3.62 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Lupin Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Lupin Limited - Total Assets Trend (2004–2025)

This chart illustrates how Lupin Limited's total assets have evolved over time, based on quarterly financial data. See LUPIN net asset value for net asset value and shareholders' equity analysis.

Lupin Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Lupin Limited's total assets of Rs335.00 Billion consist of 57.5% current assets and 42.5% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 5.3%
Accounts Receivable Rs55.02 Billion 18.8%
Inventory Rs54.76 Billion 18.8%
Property, Plant & Equipment Rs55.04 Billion 18.8%
Intangible Assets Rs25.00 Billion 8.6%
Goodwill Rs22.33 Billion 7.6%

Asset Composition Trend (2004–2025)

This chart illustrates how Lupin Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LUPIN market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Lupin Limited's current assets represent 57.5% of total assets in 2025, an increase from 56.0% in 2004.
  • Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 2.5% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2004.
  • Asset Diversification: The largest asset category is property, plant & equipment at 18.8% of total assets.

Lupin Limited Competitors by Total Assets

Key competitors of Lupin Limited based on total assets are shown below.

Company Country Total Assets
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
Almirall S.A.
MC:ALM
Spain €2.36 Billion
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
China CN¥8.25 Billion
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
China CN¥1.41 Billion
ANI Pharmaceuticals Inc
NASDAQ:ANIP
USA $1.44 Billion
North China Pharmaceutical Co Ltd
SHG:600812
China CN¥21.45 Billion

Lupin Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.87 1.88 1.54
Quick Ratio 1.32 1.22 1.08
Cash Ratio 0.28 0.18 0.00
Working Capital Rs94.45 Billion Rs70.30 Billion Rs46.71 Billion

Lupin Limited - Advanced Valuation Insights

This section examines the relationship between Lupin Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.15
Latest Market Cap to Assets Ratio 0.04
Asset Growth Rate (YoY) 21.7%
Total Assets Rs292.05 Billion
Market Capitalization $12.25 Billion USD

Valuation Analysis

Below Book Valuation: The market values Lupin Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Lupin Limited's assets grew by 21.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Lupin Limited (2004–2025)

The table below shows the annual total assets of Lupin Limited from 2004 to 2025.

Year Total Assets Change
2025-03-31 Rs292.05 Billion
≈ $3.16 Billion
+21.70%
2024-03-31 Rs239.97 Billion
≈ $2.60 Billion
+4.54%
2023-03-31 Rs229.56 Billion
≈ $2.48 Billion
+5.20%
2022-03-31 Rs218.21 Billion
≈ $2.36 Billion
-7.58%
2021-03-31 Rs236.10 Billion
≈ $2.55 Billion
-5.50%
2020-03-31 Rs249.84 Billion
≈ $2.70 Billion
-10.61%
2019-03-31 Rs279.49 Billion
≈ $3.02 Billion
+6.25%
2018-03-31 Rs263.05 Billion
≈ $2.84 Billion
-1.13%
2017-03-31 Rs266.07 Billion
≈ $2.88 Billion
+17.60%
2016-03-31 Rs226.25 Billion
≈ $2.45 Billion
+72.21%
2015-03-31 Rs131.38 Billion
≈ $1.42 Billion
+28.73%
2014-03-31 Rs102.06 Billion
≈ $1.10 Billion
+14.50%
2013-03-31 Rs89.14 Billion
≈ $964.00 Million
+11.67%
2012-03-31 Rs79.82 Billion
≈ $863.25 Million
+30.34%
2011-03-31 Rs61.24 Billion
≈ $662.33 Million
+20.43%
2010-03-31 Rs50.85 Billion
≈ $549.97 Million
+23.01%
2009-03-31 Rs41.34 Billion
≈ $447.09 Million
+22.90%
2008-03-31 Rs33.64 Billion
≈ $363.78 Million
+48.64%
2007-03-31 Rs22.63 Billion
≈ $244.73 Million
+12.71%
2006-03-31 Rs20.08 Billion
≈ $217.13 Million
+48.25%
2005-03-31 Rs13.54 Billion
≈ $146.46 Million
+10.10%
2004-03-31 Rs12.30 Billion
≈ $133.02 Million
--

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic
Market Cap
$12.25 Billion
Rs1.13 Trillion INR
Market Cap Rank
#1894 Global
#75 in India
Share Price
Rs2478.50
Change (1 day)
+1.44%
52-Week Range
Rs1851.80 - Rs2503.30
All Time High
Rs2503.30
About

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutica… Read more